Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: contributions to development and maintenance of addiction.

Kutlu MG, Gould TJ.

Learn Mem. 2016 Sep 15;23(10):515-33. doi: 10.1101/lm.042192.116. Print 2016 Oct.

PMID:
27634143
2.

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review.

Copeland J, Pokorski I.

Subst Abuse Rehabil. 2016 May 3;7:41-53. doi: 10.2147/SAR.S89857. eCollection 2016. Review.

PMID:
27217809
3.

Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review.

Angarita GA, Emadi N, Hodges S, Morgan PT.

Addict Sci Clin Pract. 2016 Apr 26;11(1):9. doi: 10.1186/s13722-016-0056-7. Review.

PMID:
27117064
4.

Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.

Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M.

Psychopharmacology (Berl). 2016 Jul;233(13):2469-78. doi: 10.1007/s00213-016-4298-6. Epub 2016 Apr 16.

PMID:
27085870
5.

Screening Medications for the Treatment of Cannabis Use Disorder.

Panlilio LV, Justinova Z, Trigo JM, Le Foll B.

Int Rev Neurobiol. 2016;126:87-120. doi: 10.1016/bs.irn.2016.02.005. Epub 2016 Mar 10. Review.

PMID:
27055612
6.

Treatment of Cannabis Use Disorder: Current Science and Future Outlook.

Sherman BJ, McRae-Clark AL.

Pharmacotherapy. 2016 May;36(5):511-35. doi: 10.1002/phar.1747. Review.

PMID:
27027272
7.

Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.

Trigo JM, Lagzdins D, Rehm J, Selby P, Gamaleddin I, Fischer B, Barnes AJ, Huestis MA, Le Foll B.

Drug Alcohol Depend. 2016 Apr 1;161:298-306. doi: 10.1016/j.drugalcdep.2016.02.020. Epub 2016 Feb 23.

PMID:
26925704
8.
9.

The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.

Bisaga A, Sullivan MA, Glass A, Mishlen K, Pavlicova M, Haney M, Raby WN, Levin FR, Carpenter KM, Mariani JJ, Nunes EV.

Drug Alcohol Depend. 2015 Sep 1;154:38-45. doi: 10.1016/j.drugalcdep.2015.05.013. Epub 2015 Jul 8.

PMID:
26187456
10.

Cannabis and psychopathology: The meandering journey of the last decade.

Ghosh A, Basu D.

Indian J Psychiatry. 2015 Apr-Jun;57(2):140-9. doi: 10.4103/0019-5545.158134. Review.

PMID:
26124519
11.

Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.

Haney M, Ramesh D, Glass A, Pavlicova M, Bedi G, Cooper ZD.

Neuropsychopharmacology. 2015 Oct;40(11):2489-98. doi: 10.1038/npp.2015.108. Epub 2015 Apr 16.

PMID:
25881117
12.

Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity.

Pacek LR, Mauro PM, Martins SS.

Drug Alcohol Depend. 2015 Apr 1;149:232-44. doi: 10.1016/j.drugalcdep.2015.02.009. Epub 2015 Feb 17.

PMID:
25735467
13.

Pharmacotherapies for cannabis dependence.

Marshall K, Gowing L, Ali R, Le Foll B.

Cochrane Database Syst Rev. 2014;(12):CD008940. doi: 10.1002/14651858.CD008940.pub2. Epub 2014 Dec 17. Review.

PMID:
25515775
14.

Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting.

Lam PW, Frost DW.

BMJ Case Rep. 2014 Sep 22;2014. pii: bcr2014205287. doi: 10.1136/bcr-2014-205287.

PMID:
25246463
15.

Novel Pharmacologic Approaches to Treating Cannabis Use Disorder.

Balter RE, Cooper ZD, Haney M.

Curr Addict Rep. 2014 Jun 1;1(2):137-143.

PMID:
24955304
16.

Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders.

Vandrey R, Babson KA, Herrmann ES, Bonn-Miller MO.

Int Rev Psychiatry. 2014 Apr;26(2):237-47. doi: 10.3109/09540261.2014.901300. Review.

PMID:
24892898
17.

Behavioral therapies for treatment-seeking cannabis users: a meta-analysis of randomized controlled trials.

Davis ML, Powers MB, Handelsman P, Medina JL, Zvolensky M, Smits JA.

Eval Health Prof. 2015 Mar;38(1):94-114. doi: 10.1177/0163278714529970. Epub 2014 Apr 2.

PMID:
24695072
18.

Pericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trial.

Morley KC, Haber PS, Morgan ML, Samara F.

Subst Abuse Rehabil. 2012 May 28;3:43-7. doi: 10.2147/SAR.S30052. eCollection 2012.

PMID:
24474865
19.

Time-course of the DSM-5 cannabis withdrawal symptoms in poly-substance abusers.

Hesse M, Thylstrup B.

BMC Psychiatry. 2013 Oct 12;13:258. doi: 10.1186/1471-244X-13-258.

PMID:
24118963
20.

Pharmacological strategies for detoxification.

Diaper AM, Law FD, Melichar JK.

Br J Clin Pharmacol. 2014 Feb;77(2):302-14. doi: 10.1111/bcp.12245. Review.

PMID:
24118014

Supplemental Content

Support Center